Sandeep Kumar Dhiman

Employment

• Syneos Health (India) Associate Director, Regulatory Affairs
  2022 - Present
• Syneos Health (India) Senior Manager
  2021 - Present
• Kinapse India Scientific Services Pvt. Ltd. Senior Manager
  2013 - 2021
• Kinapse India Scientific Services Pvt. Ltd. Manager
  2010 - 2012
• Ranbaxy Research Laboratories Senior Research Scientist
  2004 - 2010

Education

• Maharshi Dayanand University Rohtak Ph.D
  2017 - Present
• Manipal College of Pharmaceutical Sciences M. Pharmacy
  2002 - 2004
• Hindu College of Pharmacy B. Pharmacy
  1997 - 2001

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• SAHPRA - Relevance of the New South African Health Products Regulatory Authority and Opportunities Ahead
  Journal of Regulatory Science 2021
  +Save
• SAHPRA - Relevance of the New South African Health Products Regulatory Authority and Opportunities Ahead
  Journal of Regulatory Science 2021 DOI: 10.21423/JRS-V09I2DUREJA
  +Save
• Comparative Analysis of Evolution of Regulatory Environment in USA, Europe and Japan
  The Pharma Innovation International Journal 2021 DOI: 10.22271/tpi.2021.v10.i2a.5657
  +Save
• Exploration of Heterocyclic Compounds in Cancer Therapeutics
  Annals of the Romanian Society for Cell Biology 2020
  +Save
• Prediction of anti-viral activity of Ipomoea carnea
  Annals of the Romanian Society for Cell Biology 2020
  +Save
• A Review On Marketed Herbal Formulations With ImmunoModulating Potential
  Elementary Education Online 2020
  +Save
• Novel Drug Delivery System: Resealed Erythrocytes
  Turkish Journal of Computer and Mathematics Education 2020
  +Save
• Significance of and Challenges in Regulating Endocrine Disruptors – How Regulators and Industry can Conquer?
  Endocrine, Metabolic & Immune Disorders - Drug Targets 2020 DOI: 10.2174/1871530320666200606225104
  +Save
• Partnership Efforts – Their Potential to Reduce the Challenges that Confront Regulators and Pharmaceutical Industry
  Applied Clinical Research, Clinical Trials & Regulatory Affairs 2019 DOI: 10.2174/2213476X06999190206120109
  +Save
• The Breakthrough Hatch Waxman Amendment – A Shared Benefit for Innovations and Subsequent Innovations
  Applied Clinical Research, Clinical Trials & Regulatory Affairs 2017 DOI: 10.2174/2213476X04666170519125451
  +Save